Compare Koronis Pharmaceuticals vs Opal Therapeutics
Customers evaluate the quality of Koronis Pharmaceuticals's products using the following success metrics.
Overview
Koronis Pharmaceuticals is 26 yrs old and is based in United States.
Koronis Pharma develops antiviral therapeutics based on Viral Decay Acceleration, which exploits the strength of a virus to target its collapse.
Opal Therapeutics is based in Australia
Opal Therapeutics is an immunotherapy company focused on therapies for human immunodeficiency virus (HIV) and Hepatitis C (HCV), based on technology from the University of Melbourne.
Demo Video
Leadership
Richard Daifuku (Chief Executive Officer, President)
Stephen Kent (Founder)
Funding
Investors
Asset Management Ventures, Pacific Horizon Ventures
Alloy Ventures, Alta Partners
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because Koronis Pharmaceuticals has not claimed their profile.
Work for Koronis Pharmaceuticals? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Koronis Pharmaceuticals?
Claim your profile now.
Information not available because Opal Therapeutics has not claimed their profile.
Work for Opal Therapeutics? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Opal Therapeutics?
Claim your profile now.